insights_auto
Why is INO down २.०५%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
US$ १.४३
arrow_downward
-२.०५%(-०.०३०) 1D
US$ १.४३
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर १३, १६:००:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
US$ १.४४
High
US$ १.४८
Low
US$ १.३९
Mkt. cap
२६.७८ करोड
Avg. vol.
१.९३ करोड
Volume
५२.१९ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ ०.८०
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
Open
US$ १.४४
High
US$ १.४८
Low
US$ १.३९
Mkt. cap
२६.७८ करोड
Avg. vol.
१.९३ करोड
Volume
५२.१९ लाख
52-wk high
US$ २.७२
52-wk low
US$ ०.५६
EPS
-US$ ०.८०
Beta
१.७१
Shares outstanding
१८.७३ करोड
No. of employees
११२
News stories
From web sources and news partners
News Corp
·
९ घण्टा पहिले
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors
Seeking Alpha
·
१४ घण्टा पहिले
Inovio Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:INO) 2026-11-13
News Corp
·
१ दिन पहिले
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
MarketWatch
·
१ दिन पहिले
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc